Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


05.11.2018

3 AJR Am J Roentgenol
1 Am J Respir Crit Care Med
4 BMC Cancer
1 Br J Cancer
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
3 Cancer Res
1 Carcinogenesis
3 Clin Lung Cancer
1 Eur J Cancer
1 Int J Cancer
3 Int J Oncol
2 J Cancer Res Clin Oncol
3 J Thorac Oncol
1 PLoS One
2 Proc Natl Acad Sci U S A
2 Science
2 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. AVILA NA, Dwyer AJ, Moss J
    Reply to "Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive".
    AJR Am J Roentgenol. 2018;210:W132.
    PubMed     Text format    

  2. TROUT AT, Towbin AJ, Franz DN
    Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive.
    AJR Am J Roentgenol. 2018;210:W131.
    PubMed     Text format    

  3. CHANG S, Hur J, Hong YJ, Lee HJ, et al
    Adverse Prognostic CT Findings for Patients With Advanced Lung Adenocarcinoma Receiving First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy.
    AJR Am J Roentgenol. 2017 Nov 1:1-9. doi: 10.2214/AJR.17.18167.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  4. THOMSON CC, Mckee AB
    American Thoracic Society/American Lung Association Lung Cancer Screening Implementation Guide.
    Am J Respir Crit Care Med. 2018;198:1120-1121.
    PubMed     Text format    


    BMC Cancer

  5. KIM MC, Hwang SH, Kim NY, Lee HS, et al
    Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
    BMC Cancer. 2018;18:819.
    PubMed     Text format     Abstract available

  6. VAUGHN CP, Costa JL, Feilotter HE, Petraroli R, et al
    Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
    BMC Cancer. 2018;18:828.
    PubMed     Text format     Abstract available

  7. FUMET JD, Wickre M, Jacquot JP, Bizollon MH, et al
    Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.
    BMC Cancer. 2018;18:839.
    PubMed     Text format     Abstract available

  8. YI YS, Ban WH, Sohng KY
    Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    BMC Cancer. 2018;18:1053.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. PASSIGLIA F, Cappuzzo F, Alabiso O, Bettini AC, et al
    Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
    Br J Cancer. 2018 Oct 31. pii: 10.1038/s41416-018-0234.
    PubMed     Text format     Abstract available


    Cancer

  10. MORGENSZTERN D, Cobo M, Ponce Aix S, Postmus PE, et al
    ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31779.
    PubMed     Text format     Abstract available

  11. GOLDBERG SB, Herbst RS
    Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for patients with metastatic non-small cell lung cancer?
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31681.
    PubMed     Text format    


    Cancer Epidemiol Biomarkers Prev

  12. NIU Y, Su M, Wu Y, Fu L, et al
    Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0723.
    PubMed     Text format     Abstract available


    Cancer Res

  13. HOU P, Li L, Chen F, Chen Y, et al
    PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0883.
    PubMed     Text format     Abstract available

  14. YANG Y, Leonard M, Zhang Y, Zhao D, et al
    HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
    Cancer Res. 2018;78:422-435.
    PubMed     Text format     Abstract available

  15. BYRD TT, Fousek K, Pignata A, Szot C, et al
    TEM8/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer.
    Cancer Res. 2017 Nov 28. pii: 0008-5472.CAN-16-1911.
    PubMed     Text format     Abstract available


    Carcinogenesis

  16. CHUDASAMA D, Bo V, Hall M, Anikin V, et al
    Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
    Carcinogenesis. 2018;39:407-417.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  17. PATEL JD, Paz-Ares L, Zinner RG, Barlesi F, et al
    Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
    Clin Lung Cancer. 2018;19:e823-e830.
    PubMed     Text format     Abstract available

  18. XIE H, Wang H, Xu L, Li M, et al
    Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Clin Lung Cancer. 2018;19:484-492.
    PubMed     Text format     Abstract available

  19. SCHLEI Z, Tan W, Faber MG, Chen H, et al
    Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
    Clin Lung Cancer. 2018;19:467-475.
    PubMed     Text format     Abstract available


    Eur J Cancer

  20. WIJN DH, Groeneveld GH, Vollaard AM, Muller M, et al
    Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.
    Eur J Cancer. 2018;104:182-187.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. XIA Y, Cai XY, Fan JQ, Zhang LL, et al
    The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Int J Cancer. 2018 Oct 29. doi: 10.1002/ijc.31958.
    PubMed     Text format     Abstract available


    Int J Oncol

  22. JIANG F, Yu Q, Chu Y, Zhu X, et al
    MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.
    Int J Oncol. 2018 Oct 29. doi: 10.3892/ijo.2018.4610.
    PubMed     Text format     Abstract available

  23. HUANG FX, Chen HJ, Zheng FX, Gao ZY, et al
    LncRNA BLACAT1 is involved in chemoresistance of nonsmall cell lung cancer cells by regulating autophagy.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4614.
    PubMed     Text format     Abstract available

  24. ABRAHAM V, Cao G, Parambath A, Lawal F, et al
    Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.
    Int J Oncol. 2018;53:488-502.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  25. KIRCHBERGER MC, Schilling B, Haferkamp S, Bosserhoff A, et al
    Can checkpoint inhibitor therapy improve response to chemotherapy?
    J Cancer Res Clin Oncol. 2018;144:183-185.
    PubMed     Text format    

  26. KORDIAK J, Szemraj J, Grabska-Kobylecka I, Bialasiewicz P, et al
    Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate.
    J Cancer Res Clin Oncol. 2018 Oct 27. pii: 10.1007/s00432-018-2779.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  27. SCHROCK AB, Welsh A, Chung JH, Pavlick D, et al
    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer.
    J Thorac Oncol. 2018 Oct 24. pii: S1556-0864(18)33205.
    PubMed     Text format     Abstract available

  28. YOSHIDA H, Ooi M, Kim YH
    Successful Treatment with Osimertinib and Chemotherapy in a Non-Small Cell Lung Cancer Patient with EGFR Mutation and Meningeal Carcinomatosis.
    J Thorac Oncol. 2018;13:e219-e220.
    PubMed     Text format    

  29. RICCIUTI B, Marcomigni L, Metro G, Bellezza G, et al
    Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib.
    J Thorac Oncol. 2018;13:e220-e222.
    PubMed     Text format    


    PLoS One

  30. FU JY, Wan YL, Huang TY, Wu CF, et al
    Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection.
    PLoS One. 2018;13:e0206386.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  31. ROBICHAUD N, Hsu BE, Istomine R, Alvarez F, et al
    Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.
    Proc Natl Acad Sci U S A. 2018;115:E2202-E2209.
    PubMed     Text format     Abstract available

  32. SHI L, Li K, Guo Y, Banerjee A, et al
    Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.
    Proc Natl Acad Sci U S A. 2018 Oct 31. pii: 1804931115.
    PubMed     Text format     Abstract available


    Science

  33. ALBRENGUES J, Shields MA, Ng D, Park CG, et al
    Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.
    Science. 2018;361.
    PubMed     Text format     Abstract available

  34. BUGAJ LJ, Sabnis AJ, Mitchell A, Garbarino JE, et al
    Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway.
    Science. 2018;361.
    PubMed     Text format     Abstract available


    Thorax

  35. METS OM, Schaefer-Prokop CM, de Jong PA
    Primary lung cancer in patients with previous malignancies: a nationwide study.
    Thorax. 2018 Nov 1. pii: thoraxjnl-2018-211891.
    PubMed     Text format     Abstract available

  36. POWELL HA
    Socioeconomic deprivation and inequalities in lung cancer: time to delve deeper?
    Thorax. 2018 Oct 31. pii: thoraxjnl-2018-212362.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: